Childhood Immunization - PowerPoint PPT Presentation

1 / 34
About This Presentation
Title:

Childhood Immunization

Description:

Childhood Immunization Directed by : Dr. J. Halazoun Presented by : Dr. F. Abu Eida ROUTINE VACCINES IN CHILDHOOD & ADOLESCENSE ALL CHILDREN SHOULD BE VACCINATED ... – PowerPoint PPT presentation

Number of Views:2328
Avg rating:5.0/5.0
Slides: 35
Provided by: doct4
Category:

less

Transcript and Presenter's Notes

Title: Childhood Immunization


1
Childhood Immunization
  • Directed by Dr. J. Halazoun
  • Presented by Dr. F. Abu Eida

2
ROUTINE VACCINES IN CHILDHOOD ADOLESCENSE
  • ALL CHILDREN SHOULD BE VACCINATED AGAINST
  • Diphtheria,Tetanus,Pertussis,Polio
    Myelitis,Measles, Mumps, Rubella, Hepatitis B
    Varicella , unless contraindicated.
  • Completion of the vaccination schedule by 18
    months of age requires 16-20 injection, in 4-5
    visits .
  • The number of injections is likely to be reduced
    by the introduction of combination vaccines.

3
General Rules for all Vaccines
  • True Contraindications
  • Serious allergic reaction after previous vaccine
    dose.
  • Serious allergic reaction to vaccine component.
  • Precautions
  • Moderate to severe acute illness with or without
    fever.

4
Untrue contraindications
  • Mild acute illness with or without fever.
  • Mild to moderate local reaction (swelling ,
    redness) , low grade or moderate fever after
    previous dose.
  • Current anti microbial therapy.
  • Convalescent phase of illness
  • Premature birth ( hepB is an exception in certain
    circumstances)
  • History of penicillin allergy, other non vaccine
    allergies
  • Recent exposure to an infectious disease

5
(No Transcript)
6
Hepatitis B Vaccine
  • All infants should receive the first dose soon
    after birth , before hospital discharge .
  • Infants born to HBsAg ve mothers should receive
    the 2nd dose at least one month after the 1st
    dose.
  • The 3rd dose should be given at least 4 months
    after the second dose, but not before 6 months of
    age.
  • Infants of HBsAg ve mother should receive
    hepatitis B vaccine and 0.5 ml HepB Ig within 12
    hours after birth, at separate sites.

7
Hepatitis B Vaccine
  • The second dose is recommended at 1-2 month of
    age 3rd dose at 6 month of age.
  • Infants of mothers of unknown HBsAg status should
    receive HBV vaccine within 12 hrs of birth
    maternal blood should be drawn at delivery to
    determine the mother status.
  • If HBs Ag is ve the infant should receive HB Ig
    as soon as possible ( not later than 1/52 of age).

8
Hepatitis B Vaccine
9
DTaP Vaccine
  • The 4th dose of DTaP may be administered as early
    as 12 month of age, provided 6/12 have elapsed
    since the 3rd dose if the child is unlikely to
    return at age 15 18 month.
  • Tetanus diphtheria toxoids (Td) is recommended
    at age 11-12 yrs, if at least 5 yrs have elapsed
    since the last dose.
  • Subsequent routine (Td) boosters are recommended
    every 10 yrs.

10
Contraindications
  • Encephalopathy ( coma , decreased level of
    consciousness, prolonged seizures ) within 7 days
    of administration of previous dose.
  • Progressive Neurologic disorder including
    Infantile spasm , uncontrolled epilepsy ,
    progressive Encephalopathy, defer DTaP until
    neurologic status clarified .

11
Precautions
  • Fever of 40.5 ?c or more , within 48 hrs after
    vaccination with previous dose of DTP or DTaP .
  • Collapse or shock like state
  • Hyporesponsive Hypotonic episode within 48 hrs
    after receiving previous dose of DTP or DTaP.
  • Seizures within 3 days of receiving previous dose
    of DTP or DTaP.
  • Persistent , inconsolable crying lasting gt 3 hrs
    lt 48 hrs after previous dose.
  • Guillian- Barre Syndrome within 6 weeks after
    previous dose.

12
These are not contraindications
  • Temperature lt 40.5
  • Fussiness or mild drowsiness after previous dose.
  • Family Hx of seizures .
  • Family Hx of SIDS
  • Family Hx of adverse reaction after DTP or DTaP
    vaccination.
  • Stable neurologic condition ( CP, well controlled
    convulsions , developmental delay)

13
DTP continue
  • Pertussis is common in developing countries and
    some developed nations ,where immun. Is not
    provided.
  • Protection is attained with four doses and
    booster at 4-6 yr of age
  • DT should be used for children who are younger
    than 7years and who have contraindication to
    pertussis vaccine . Pertussis vacc. Has not
    recommended for persons 7 yr of age or older.
  • Dose and administration0.5ml in anterolateral
    thigh.
  • Acetaminophen administered before DTaP or DTP
    vaccination and thereafter every 4 hours for 24
    hours,for children with personal or family Hx of
    convulsions

14
Hib Conjugate Vaccine
  • Vaccine is administered at 2/12 4/12 (a dose
    at 6/12 not required).
  • Contraindications Age below 6 weeks.
  • Precautions moderate to severe acute illness
    with or without fever.

15
IPV OPV
  • All children should receive 4 doses of IPV at age
    2,4,6-18 months and 4-6 yrs.
  • Two doses of IPV administered at ages 2 4
    months, followed by two doses of OPV at 12-18
    months 4-6 yr.
  • IPV is recommended for Immunocompromised persons
    .
  • Precaution pregnancy.

16
IPV OPV cont
  • IPV is recommended to reduce the risk of vaccine
    associated paralytic poliomyelitis associated
    with OPV.
  • OPV is recommended in areas where polio is
    endemic in unvaccinated children who will
    travel within 4 weeks to endemic areas.

17
Measles, Mumps Rubella
  • The 1st dose at 12 months or after.
  • The 2nd dose of MMR is recommended at 4-6 yrs and
    may be given during any visit .
  • Those who have not previously received the 2nd
    dose should complete the schedule by the visit at
    11- 12 yrs.

18
Contraindications
  • Immunodef.,immunosupppresive therapy ,HIV
    infection.
  • Pregnancy
  • Severe allergic reaction after previous dose or
    to vaccine component.
  • Precautions
  • thrombocytopenia hx of TP.
  • History of receipt of antibody containing bld
    products lt 11 months

19
Varicella Vaccine
  • Live attenuated Varicella virus vaccine is
    recommended at any visit , at or after age 12
    months for susceptible children.
  • Patients on salicylate therapy have a risk of
    developing Reye syndrome after vaccination.
  • Persons 13 yrs or older should receive 2 doses,
    given at least 4 weeks apart.

20
Varicella cont..
  • Varicella should not be given to a member of
    family hx of immunodef. Until the immune status
    documented.
  • Pregnancy .
  • All children 12 months of age or older ,who have
    no hx of varicella vaccination or chicken pox
    should be vaccinated .
  • Infants younger than 6 months protected by
    maternal antibodies.
  • VZIG is recommended for newborn whose mother had
    onset of chicken pox within 5 days before to2
    days after delivery
  • Children and adoles. With ALL in remission can
    receive varicella vaccine

21
Pneumococcal Vaccine
  • It is a conjugate vaccine.PCV
  • It is recommended for all children aged 2-23
    months.
  • It is also recommended for certain children aged
    24-59 months
  • Pneumococcal polysaccharide vaccinePPV is
    recommended in addition to PCV for certain high
    risk groups
  • Sickle cell disease
  • Asplenia
  • HIV
  • Congenital ID
  • CRF- nephrotic syndrome
  • Chronic cardiac disease
  • CSF leak

22
Hepatitis A Vaccine
  • It is an inactivated vaccine.
  • This vaccine is recommended for use in selected
    states regions.
  • Given in 2 doses
  • 0.5 ml for 2 17 yrs of age
  • 1 ml for 18 yrs or older
  • Protective immunity develops 2-4 weeks after
    receiving the initial vaccine dose.

23
Hepatitis A Vaccine
  • If immediate protection( before 2 weeks) is
    necessary , IM Ig can be given
  • for short protection of 1 2 months.
  • 0.02 ml / kg
  • For long time protection of 3-5 months
  • 0.06 ml / kg can be repeated every 5 months if
    exposure continues

24
Influenza Vaccine
  • Influenza vaccine is recommended for
  • persons at increased risk of complications of
    influenza.
  • The elderly.
  • Children 6 months or older
  • Asthma
  • Cardiac disease
  • Sickle cell disease
  • HIV
  • others

25
Influenza vaccine
  • Can be given annually from 6 months of age
  • 6- 35months
  • 0.25 ml
  • 3yrs or more
  • 0.5 ml
  • Children 8 yrs or less who are receiving the
    vaccine for the first time , should receive 2
    doses at least 4 weeks apart.

26
Influenza vaccine
  • Contraindications
  • Severe allergic reaction to egg protein , or
    other component
  • Untrue contraindication
  • Concurrent administration of aminophyllin
    comadine
  • Severe contact allergy to latex

27
Meningococcal Vaccine
  • Serogroup A is the most common cause of
    meningococcal meningitis.
  • Group C B are less common.
  • The quadrivalent polysaccharide A/C/Y/W- 135 is
    available in USA.
  • The vaccine is ineffective against serogroup A in
    infants less than 3 months may be partially
    effective in children 3 11months of age.

28
Meningococcal Vaccine
  • Children younger than 2 yrs , are not protected
    against serogroup C .
  • The meningococcus vaccine(0.5 ml SQ) is
    recommended for persons 2 yrs or older.
  • Children vaccinated before 4 yrs of age , should
    be revaccinated after 2 3 yrs, if they remain in
    endemic areas.

29
Meningococcal Vaccine
  • Indications
  • Functional or anatomic asplenia
  • Travel to endemic areas

30
Typhoid Vaccine
  • Recommended for persons traveling to endemic
    areas.
  • Three typhoid vaccine
  • oral vaccine
  • for 6 yrs older
  • 4 doses of one enteric coated capsule EOD
  • Repeated every 5 yrs as booster
  • 2 parenteral vaccines younger than 6 yrs
  • 0.25 ml from 6 months 10 yrs
  • 0.5 ml for 10 yrs and older

31
Rabies Immunization
  • The risk of rabies is currently the highest in
    countries where rabies in dogs is uncontrolled.
  • Children should be considered for pre exposure
    prophylaxis ,if they will be in an endemic area
    fore more than 1 month.
  • There are two available vaccines
  • HDCV Human Diploid Cell Rabies Vaccine
  • RVA Rabies Vaccine Absorbed

32
Rabies Immunization
  • Preexposure
  • 3 intradermal doses of HDCV 0.1 ml on days
    0,7,28 days.
  • RVA IM as 3 doses 1ml on days 0,7,28
  • Post exposure
  • Rabies IG given IM as 5 doses of 1 ml on days
    0, 3, 7, 14, 28,if previously unvaccinated 2
    doses on days 0, 3 if vaccinated.

33
ROTA VIRUS
  • First dose should not be given before 6 weeks .
  • C/o hypersensitivity to aminoglicoside,ampho B
    ,febrile illness ,immunodef. Precaution is acute
    vomiting or diarrhea

34
THANK YOU
  • Special thanks
  • Yaman Abou Zanouna
  • Deena abdel Hadi
Write a Comment
User Comments (0)
About PowerShow.com